Cardiac resynchronization therapy for the failing Fontan patient.
Myocardial dysfunction is the leading cause of death in single-ventricle patients. Heart transplantation has traditionally been reserved for Fontan patients with end-stage myocardial dysfunction. Cardiac resynchronization therapy with multisite pacing was found to improve the myocardial performance in Fontan patients in acute postoperative settings; however, its role is unclear in chronic Fontan patients with progressive myocardial dysfunction. We present a case in which cardiac resynchronization therapy improved both hemodynamics and clinical condition in a Fontan patient with advanced myocardial dysfunction.
Sojak
Vladimir
V
Department of Cardiovascular Surgery, University Medical Center, Ljubljana, Slovenia. vladimir.sojak@kclj.si
Mazic
Uros
U
Cesen
Maja
M
Schrader
Jurgen
J
Danojevic
Nenad
N
D002303:Cardiac Output, Low / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D004562:Electrocardiography; D004567:Electrodes, Implanted; D005500:Follow-Up Studies; D018729:Fontan Procedure; D006330:Heart Defects, Congenital / Q000601:surgery*; D006333:Heart Failure / Q000628:therapy*; D006352:Heart Ventricles / Q000002:abnormalities*; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial; D011183:Postoperative Complications / Q000628:therapy*; D012086:Reoperation